This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Peptides & Oligonucleotides

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Events

Showing 4 of 7 eventsView all events

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

September 14 -16, 2021, Online Training Course

LEARN HOW TO DEVELOP AN EVOLVING ANALYTICAL CONTROL STRATEGY FOR YOUR OLIGONUCLEOTIDE DRUG SUBSTANCE

TIDES USA: Oligonucleotide & Peptide Therapeutics

Delivered as Hybrid Event from September 20-30, 2021, Boston Convention and Exhibition Center

Industry’s Largest & Most Renowned Event to Accelerate Your Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

Introduction to Oligonucleotide Conjugate Strategies

October 26-28, 2021, Online Training Course

Understand how to best design Oligonucleotide conjugates from simple starting building blocks to the full oligonucleotide conjugate

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Delivered as Hybrid Event from 15-19 November 2021, Sheraton Airport Brussels, Belgium

The Industry’s Leading Event in Europe to Accelerate Therapeutics to Market by Expediting R&D, Improving CMC Efficiency, and Building New Partnerships

Articles & Video

Showing 9 of 64 articles & videoView all articles & video
Featured
Personalized Medicine

eBook: Personalized Peptide Vaccines & Therapies

This ebook focuses on the latest challenges and approaches in producing personalized therapies and vaccines to fight cancer and rare diseases.

Featured
Peptides and Oligonucleotides

Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021

How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.

Monthly Newsletter

Keep up to date with content on Peptide & Oligonucleotide Therapeutics

Keep up to speed every month with top content on peptide, oligonucleotide and mRNA therapeutics.

Analytical Chemistry

Analytical Strategies for Oligonucleotide and Peptide Therapeutics - TIDES eBook Series

This TIDES eBook focuses on the challenges, strategies and technologies for measuring quality of oligonucleotides and peptides in therapeutic development.

Peptide Manufacturing

Challenge to Peptide Manufacturing Technologies

COVID-19

Life Sciences Survey: COVID-19 Impacts One Year On

Partnering

45% of companies in oligonucleotide, peptide and mRNA therapeutics increased collaboration during the pandemic

Immunotherapies

Personalized Medicine: Neoantigen Cancer Vaccines and T Cell Therapy

Drug Delivery

Delivery is still biggest area of need in peptide, oligonucleotide and mRNA therapeutics

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 40,000+ TIDES executives and scientists, including 2,000+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Michael Dunnet, Head of Portfolio Sales:
michael.dunnet@informa.com | +1 (857) 504-6732

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2021 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.